N Verses Capital, LLC Blueprint Medicines Corp Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, N Verses Capital, LLC holds 3,200 shares of BPMC stock, worth $276,576. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,200
Previous 100
3100.0%
Holding current value
$276,576
Previous $9.49 Million
3535.84%
% of portfolio
0.21%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$575 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$565 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$508 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$280 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$213 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.16B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...